Camilla Soenderby

Camilla Soenderby

Director/Miembro de la Junta en BB BIOTECH AG .

Fortuna: - $ al 30/06/2026

54 años
Health Technology
Distribution Services
Finance

Perfil

Camilla Soenderby is currently Director at Affibody Medical AB, Non-Executive Director at F2G Ltd. since 2021, Director at BB Biotech AG since 2024, Independent Director at Abivax SA since 2024, and Independent Director at Inventiva SA starting in 2026.
Former roles include Head-Product Strategy Officer at Takeda Pharmaceutical Co., Ltd. from 2019 to 2020, Head-Global Product Strategy at Shire France SAS, General Manager at Schering-Plough Ltd. (Taiwan), and General Manager at AbbVie SAS (France).
Education includes undergraduate studies at the University of Copenhagen.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
28/02/2026 0 ( -.--% ) - $ 30/06/2026

Cargos activos de Camilla Soenderby

EmpresasCargoInicio
BB BIOTECH AG Director/Miembro de la Junta 21/03/2024
ABIVAX Director/Miembro de la Junta 02/04/2024
INVENTIVA Director/Miembro de la Junta 30/06/2026
Director/Miembro de la Junta 15/09/2021
Director/Miembro de la Junta -

Antiguos cargos conocidos de Camilla Soenderby.

EmpresasCargoFin
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Camilla Soenderby.

Formación de Camilla Soenderby.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

28

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Distribution Services

  1. Bolsa de valores
  2. Insiders
  3. Camilla Soenderby